Publication | Closed Access

Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma

Life StudyOncologyMedicinePharmacotherapyPreliminary EfficacyLiver CancerCancer TreatmentPharmacologyRadiation OncologyHepatocellular CarcinomaCancer ResearchAdvanced Hepatocellular Carcinoma